Corporate information
Official name
Astellas Venture Capital Limited Liability Company
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 14 of 14Company | Profile | Country | Funding | ||
---|---|---|---|---|---|
CoMentis Inc | N/A | ||||
DecImmune Therapeutics Inc | Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction | N/A | |||
Epizyme Inc | Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). | N/A | |||
Evolva Holding SA | N/A | ||||
F2G Ltd | N/A | ||||
Fate Therapeutics Inc | N/A | ||||
Inimex Pharmaceuticals Inc | N/A | ||||
Lectus Therapeutics Ltd | N/A | ||||
Nereus Pharmaceuticals Inc | N/A | ||||
PhaseBio Pharmaceuticals Inc | N/A | ||||
TaiGen Biotechnology Co Ltd | Pharmaceutical company engaging in the development of novel therapeutics. | N/A | |||
Verastem Inc | N/A | ||||
Viamet Pharmaceuticals Inc | N/A | ||||
Cleave Biosciences Inc | Drug development company focused on novel targets in cellular protein homeostasis pathways | N/A |